Position in AZN
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$1,699,753
New position
Shares Held
8,964
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#561
of 1,459 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Security National Bank holds $9,534,118 across 10 Drug Manufacturers - General names. AZN ranks #3 (17.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
15,085 | $3,831,137 | |
| 2 | LLY |
ELI LILLY & Co
|
2,326 | $2,789,874 | |
| 3 | AZN |
Astrazeneca PLC
This page
|
8,964 | $1,699,753 | |
| 4 | AMGN |
Amgen Inc
|
1,713 | $620,311 | |
| 5 | ABBV |
AbbVie Inc.
|
1,182 | $297,437 | |
| 6 | GSK |
GSK plc
|
2,359 | $123,658 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,294 | $74,560 | |
| 8 | PFE |
Pfizer Inc
|
2,522 | $60,729 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,699,753 | 8,964 | Shares | Sole | 2026-07-15 | |
| No filing history on record for this holder in this stock. | ||||||